Qu Biologics Initiates Study of Site Specific Immunomodulators at Geisel School of Medicine at Dartmouth VANCOUVER, BRITISH COLUMBIA--(Marketwired - July 3, 2013) - Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs) that aim to "reboot" the body's...